Literature DB >> 19298434

Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909-1958.

Simon D Shorvon1.   

Abstract

This paper provides a review of the drug treatment of epilepsy from 1909, the year of the foundation of the International League Against Epilepsy (ILAE), to 1958. It was during this period that modern approaches to the medicinal therapy of epilepsy were formulated and many new drugs were introduced. Of these, both phenytoin and phenobarbital continue to be widely used today. This was the period when scientific screening was also introduced into drug discovery. The leading figures in the ILAE played an important role in guiding the evolution of the treatment of epilepsy during this period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298434     DOI: 10.1111/j.1528-1167.2009.02041.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action.

Authors:  Jan M Keppel Hesselink; David J Kopsky
Journal:  J Neurol       Date:  2017-01-12       Impact factor: 4.849

2.  Drug Resistant Epilepsy and New AEDs: Two Perspectives.

Authors: 
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

Review 3.  Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors:  Martin Holtkamp
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 4.  Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2017-03-13       Impact factor: 3.996

Review 5.  Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy.

Authors:  Frank M C Besag; Michael J Vasey
Journal:  Paediatr Drugs       Date:  2021-05-06       Impact factor: 3.022

Review 6.  Stem Cell Therapy in Treating Epilepsy.

Authors:  Bao-Luen Chang; Kuo-Hsuan Chang
Journal:  Front Neurosci       Date:  2022-06-27       Impact factor: 5.152

7.  Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.

Authors:  Yi Wang; Xiaoying Ying; Liying Chen; Yao Liu; Ying Wang; Jiao Liang; Cenglin Xu; Yi Guo; Shuang Wang; Weiwei Hu; Yongzhong Du; Zhong Chen
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 8.  New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?

Authors:  Jacqueline A French; Deana M Gazzola
Journal:  Ther Adv Drug Saf       Date:  2011-08

9.  Seizures induced by pentylenetetrazole in the adult zebrafish: a detailed behavioral characterization.

Authors:  Ben Hur M Mussulini; Carlos E Leite; Kamila C Zenki; Luana Moro; Suelen Baggio; Eduardo P Rico; Denis B Rosemberg; Renato D Dias; Tadeu M Souza; Maria E Calcagnotto; Maria M Campos; Ana M Battastini; Diogo L de Oliveira
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

10.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.